The sessile serrated adenoma (SSA) is a type of polyp that is found in the colon and rectum. It is a rare form of polyp, and is often difficult to diagnose. It is a precursor to colorectal cancer, and can be difficult to detect. In this article, we will discuss the mystery of the SSA, and what doctors can do to uncover it.
An SSA is a type of polyp that is found in the colon and rectum. It is a precursor to colorectal cancer, and can be difficult to detect. It is a sessile (non-mobile) polyp that has a serrated (saw-toothed) shape. It is usually small, and can be found on the inner wall of the colon or rectum.
The most common symptom of an SSA is rectal bleeding. Other symptoms can include abdominal pain, changes in bowel habits, and weight loss. It is important to note that many of these symptoms can be indicative of other conditions, so it is important to see a doctor if any of these symptoms are present.
The diagnosis of an SSA is usually done through a colonoscopy. During this procedure, the doctor will examine the lining of the colon and rectum, and will look for any polyps. If an SSA is found, it will be biopsied to determine if it is cancerous or not. If the SSA is found to be cancerous, it will need to be removed. This can be done through a colonoscopy or a surgical procedure. In some cases, chemotherapy or radiation may be recommended.
There are several risk factors for developing an SSA. These include age, family history, and lifestyle factors. People over the age of 50 are more likely to develop an SSA. People who have a family history of colorectal cancer are also at an increased risk. Lifestyle factors such as smoking, a diet high in fat and red meat, and a lack of physical activity can also increase the risk.
There are several steps that can be taken to reduce the risk of developing an SSA. These include eating a healthy diet, exercising regularly, quitting smoking, and getting regular screenings. People over the age of 50 should have a colonoscopy every 10 years to check for polyps.
The sessile serrated adenoma (SSA) is a rare form of polyp that can be difficult to diagnose. It is a precursor to colorectal cancer, and can be difficult to detect. There are several risk factors for developing an SSA, including age, family history, and lifestyle factors. It is important for doctors to be aware of the symptoms and risk factors for an SSA, and to recommend regular screenings to their patients. By taking these steps, doctors can help to uncover the mystery of the SSA and reduce the risk of colorectal cancer.
1.
Breast Cancer Patients Living Longer Post-Medicaid Expansion
2.
Error on the MGUS-Autoimmune Disease Association.
3.
Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.
4.
The majority of cancer medications that receive expedited approval end up failing confirmatory trials.
5.
Unified Neuro/Psych Residency Program: New Proposal.
1.
Optimizing Melanoma Treatment: Strategies in Diagnosis, Clinical Research, and Physician Training
2.
Hemoglobin C: Understanding its Role in Sickle Cell Disease
3.
Beyond the Human Eye: How AI Is Redefining Brain Cancer Diagnosis Through Advanced Imaging
4.
Understanding Abemaciclib: A Breakthrough Treatment for Breast Cancer
5.
The Growing Challenge of Haematological Malignancies in Older Adults
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
4.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation